Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Legendre

Showing results (11-20 of 456) with videos related to

Pageof 46
Sort By:
Nature Reviews. Nephrology|April 3, 2013
Transplantation: Proteinuria in kidney transplantation: an ongoing storyChristophe Legendre, Dany Anglicheau
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 2, 2017
Response to: "Renal allograft histology at 10 years after transplantation in the tacrolimus era: Evidence of pervasive chronic injury"Renaud Snanoudj, Christophe Legendre
Transplantation Reviews (Orlando, Fla.)|July 18, 2008
mToR inhibitors-induced proteinuria: mechanisms, significance, and managementEmmanuel Letavernier, Christophe Legendre
Transplantation|April 4, 2015
From Mean Fluorescence Intensity to C1q-Binding: The Saga of Anti-HLA Donor-specific AntibodiesAlexandre Loupy, Christophe Legendre
Kidney International|February 14, 2014
Delayed kidney graft function: from mechanism to translationBernd Schröppel, Christophe Legendre
Nephrologie & Therapeutique|March 13, 2016
[New aspects of HLA compatibility in organ transplantation]Renaud Snanoudj, Christophe Legendre
Nephrologie & Therapeutique|September 13, 2006
[New diagnostic tools in renal transplantation]Eric Thervet, Christophe Legendre
Presse Medicale (Paris, France : 1983)|January 17, 2012
[Kidney allograft: a target for systemic disease]Guillaume Canaud, Christophe Legendre
Expert Opinion on Drug Safety|December 21, 2012
Adverse events associated with mTOR inhibitorsNicolas Pallet, Christophe Legendre
Transplantation|March 28, 2014
T-cell-depleting antibodies and risk of cancer after transplantationRenaud Snanoudj, Christophe Legendre
Pageof 46

Showing results (11-20 of 456) with videos related to

Sort By:
Pageof 46
Nature Reviews. Nephrology|April 3, 2013
Transplantation: Proteinuria in kidney transplantation: an ongoing storyChristophe Legendre, Dany Anglicheau
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 2, 2017
Response to: "Renal allograft histology at 10 years after transplantation in the tacrolimus era: Evidence of pervasive chronic injury"Renaud Snanoudj, Christophe Legendre
Transplantation Reviews (Orlando, Fla.)|July 18, 2008
mToR inhibitors-induced proteinuria: mechanisms, significance, and managementEmmanuel Letavernier, Christophe Legendre
Transplantation|April 4, 2015
From Mean Fluorescence Intensity to C1q-Binding: The Saga of Anti-HLA Donor-specific AntibodiesAlexandre Loupy, Christophe Legendre
Kidney International|February 14, 2014
Delayed kidney graft function: from mechanism to translationBernd Schröppel, Christophe Legendre
Nephrologie & Therapeutique|March 13, 2016
[New aspects of HLA compatibility in organ transplantation]Renaud Snanoudj, Christophe Legendre
Nephrologie & Therapeutique|September 13, 2006
[New diagnostic tools in renal transplantation]Eric Thervet, Christophe Legendre
Presse Medicale (Paris, France : 1983)|January 17, 2012
[Kidney allograft: a target for systemic disease]Guillaume Canaud, Christophe Legendre
Expert Opinion on Drug Safety|December 21, 2012
Adverse events associated with mTOR inhibitorsNicolas Pallet, Christophe Legendre
Transplantation|March 28, 2014
T-cell-depleting antibodies and risk of cancer after transplantationRenaud Snanoudj, Christophe Legendre
Pageof 46